A Clinical Study on the Treatment of Cerebral Small Vascular Disease
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the safety and efficacy of butylphthalide (NBP) in the
treatment of cerebral small vessel disease through a multicenter, randomized,double-blind,
placebo-controlled study. Butylphthalide Soft Capsule and placebo were prescribed to the
experimental group and the control group for a period of 24-months, respectively. After that,
the experimental group and the control group were given Butylphthalide Soft Capsule for 6
months.